Ralph Lauren Form 4: Chief Product Officer reduces stake to 24,115 shares

Rhea-AI Filing Summary

Halide Alagoz, Chief Product Officer at Ralph Lauren Corporation (RL), reported a sale of Class A common stock on 09/04/2025. The Form 4 shows 2,337 shares were sold at a reported price of $317 per share, reducing her beneficial holdings to 24,115 shares. The filing states the sale was made for estate planning and investment diversification. The Form 4 is signed by an attorney-in-fact on 09/05/2025.

Positive

• Disclosure completeness: The Form 4 includes transaction date, number of shares sold, price, and post-transaction holdings.
• Stated non-operational rationale: The filer explicitly cites estate planning and investment diversification as the reason for the sale.

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sale of 2,337 shares at $317 reduces holdings to 24,115; disclosed reason is estate planning and diversification.

The transaction is a straightforward, reported open-market sale by an executive officer rather than a derivative exercise or grant. The stated purpose is non-operational (estate planning and diversification), which is common for executive-level sales. The sale amount and remaining ownership are explicitly reported, allowing investors to update insider-holding tables. There is no additional company operational or financial information provided in this filing.

Corporate Governance Expert

TL;DR: A single-line Form 4 discloses a routine officer sale with a stated non-business rationale.

The filing correctly identifies the reporting person as an officer and discloses the transaction date, number of shares sold, price per share, and post-transaction holdings. The explanation cites estate planning and diversification, which is an accepted non-material rationale for disposition. Documentation appears procedurally complete with an attorney-in-fact signature. The filing does not indicate any plans that would suggest material governance or control changes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alagoz Halide

(Last) (First) (Middle)

RALPH LAUREN CORPORATION

650 MADISON AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RALPH LAUREN CORP [ RL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/04/2025		S		2,337	D	$317(1)	24,115	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was made in connection with a long-term strategy for estate planning and investment diversification.

	/s/ Avery S. Fischer, Attorney-in-Fact for Halide Alagoz	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Halide Alagoz report on Form 4 for RL?

The Form 4 reports a sale of 2,337 shares of Class A common stock on 09/04/2025 at a reported price of $317 per share.

How many RL shares does Halide Alagoz own after the reported sale?

The filing reports beneficial ownership of 24,115 shares following the sale.

What reason did the filer give for the sale of RL shares?

The sale was made in connection with estate planning and investment diversification, per the explanation in the Form 4.

When was the Form 4 signed and by whom?

The Form 4 is signed by Avery S. Fischer, Attorney-in-Fact for Halide Alagoz on 09/05/2025.

What is Halide Alagoz's role at Ralph Lauren Corporation?

The filing identifies Halide Alagoz as an Officer with the title Chief Product Officer.